Henlius and Intas receive Positive CHMP Opinion for HETRONIFLY® (approved as HANSIZHUANG in China) in European markets as First-Line Treatment for adult pati…
HANSIZHUANG ® (serplulimab) was the first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC – ...
Medscape1d
Europe Recommends Lung Cancer Drug Hetronifly
Hetronifly in combination with chemotherapy was shown to improve survival of patients with extensive stage small cell lung ...
FiercePharma1d
Europe's CHMP turns down Apellis' pegcetacoplan appeal, endorses new drugs from Pfizer, ImmunoGen and Henlius
Amid a parade of regulatory endorsements in Europe, Apellis Pharmaceuticals’ ophthalmology prospect pegcetacoplan has been ...
The Pharma Letter1d
Latest batch of EMA’s human medicines committee recommendations
Committee for Human Medicinal Products (CHMP) recommended approval of five novel medicines at its September meeting ...
kalkinemedia13h
Venezuela’s investment climate worsens amid political and economic turmoil
Venezuela’s once-promising investment landscape has drastically deteriorated, largely due to political turmoil and economic ...
Le Lézard12d
Breaking the silence on menopause. More than half of women 40+ say they have experienced a change in the appearance of their teeth or gums as they age
Delta Dental Insurance Company's second Oral Health and Menopause Survey reveals women 40+ aren't aware of the impact menopause has on their oral health despite experiencing symptoms, but want to ...